Artificial intelligence is changing how clinical genomics is practiced. From variant prioritization to phenotype matching and report generation, AI helps geneticists and molecular biologists focus their expertise where it matters most, while keeping every decision transparent and traceable.
In this section, you will find our articles on AI in clinical genomics: how explainable AI supports variant interpretation, what labs should look for when evaluating AI-powered bioinformatics platforms, and how SeqOne applies machine learning to accelerate diagnosis without turning analysis into a black box.

Meet UP²-SV: a dedicated AI pathogenicity classifier for structural variants, trained on 65,000+ ClinVar SVs and validated on a clinical cohort with 97.6% sensitivity. AI-powered prioritization now spans the full variant spectrum.
A Spanish hospital ended a patient's 30-year diagnostic odyssey by combining Agilent's advanced exome sequencing with SeqOne's AI platform, uncovering a rare DMD gene duplication that had eluded detection for decades.

Genekor Medical, a Romanian diagnostics lab, uses SeqOne's platform to make HRD testing a routine clinical workflow. Using shallow whole genome sequencing and automated FASTQ-to-GIS analysis, they've cut complexity and costs, proving that reliable precision oncology testing is achievable for regional labs beyond major European hubs.